82
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background—

          Adaptive T-cell response is promoted during atherogenesis and results in the differentiation of naïve CD4 +T cells to effector and/or memory cells of specialized T-cell subsets. Aim of this work was to investigate the relationship between circulating CD4 +T-cell subsets and atherosclerosis.

          Methods and Results—

          We analyzed 57 subsets of circulating CD4 +T cells by 10-parameter/8-color polychromatic flow cytometry (markers: CD3/CD4/CD45RO/CD45RA/CCR7/CCR5/CXCR3/HLA-DR) in peripheral blood from 313 subjects derived from 2 independent cohorts. In the first cohort of subjects from a free-living population ( n=183), effector memory T cells (T EM: CD3 +CD4 +CD45RA CD45RO +CCR7 cells) were strongly related with intima-media thickness of the common carotid artery, even after adjustment for age ( r=0.27; P<0.001). Of note, a significant correlation between T EM and low-density lipoproteins was observed. In the second cohort ( n=130), T EM levels were significantly increased in patients with chronic stable angina or acute myocardial infarction compared with controls. HLA-DR +T EM were the T EM subpopulation with the strongest association with the atherosclerotic process ( r=0.37; P<0.01). Finally, in animal models of atherosclerosis, T EM (identified as CD4 +CD44 +CD62L ) were significantly increased in low-density lipoprotein receptor and apolipoprotein E deficient mice compared with controls and were correlated with the extent of atherosclerotic lesions in the aortic root ( r=0.56; P<0.01).

          Conclusions—

          Circulating T EM cells are associated with increased atherosclerosis and coronary artery disease in humans and in animal models and could represent a key CD4 +T-cell subset related to the atherosclerotic process. ( J Am Heart Assoc. 2012;1:27-41.)

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics.

          T cell circulation between peripheral tissues and the lymphoid compartment is critical for immunosurveillance and host defense. However, the factors that determine whether T cells remain in peripheral tissue or return to the circulation are undefined. Here we demonstrate that the chemokine receptor CCR7 is a critical signal that determines T cell exit from peripheral tissue. Both CCR7(-) and CCR7(+) effector T cells entered mouse asthmatic lung and while CCR7(-) T cells accumulated, CCR7(+) T cells continued to migrate into afferent lymph. Delivery of both CCR7(+) and CCR7(-) T cells directly into the airways showed that only CCR7(+) T cells exited the lung and entered draining lymph nodes. Our study establishes a molecular basis for T cell exit from peripheral tissues.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes.

            Unstable angina (UA) is associated with systemic inflammation and with expansion of interferon-gamma-producing T lymphocytes. The cause of T-cell activation and the precise role of activated T cells in plaque instability are not understood. Peripheral blood T cells from 34 patients with stable angina and 34 patients with UA were compared for the distribution of functional T-cell subsets by flow cytometric analysis. Clonality within the T-cell compartment was identified by T-cell receptor spectrotyping and subsequent sequencing. Tissue-infiltrating T cells were examined in extracts from coronary arteries containing stable or unstable plaque. The subset of CD4(+)CD28(null) T cells was expanded in patients with UA and infrequent in patients with stable angina (median frequencies: 10.8% versus 1.5%, P<0.001). CD4(+)CD28(null) T cells included a large monoclonal population, with 59 clonotypes isolated from 20 UA patients. T-cell clonotypes from different UA patients used antigen receptors with similar sequences. T-cell receptor sequences derived from monoclonal T-cell populations were detected in the culprit but not in the nonculprit lesion of a patient with fatal myocardial infarction. UA is associated with the emergence of monoclonal T-cell populations, analogous to monoclonal gammopathy of unknown significance. Shared T-cell receptor sequences in clonotypes of different patients implicate chronic stimulation by a common antigen, for example, persistent infection. The unstable plaque but not the stable plaque is invaded by clonally expanded T cells, suggesting a direct involvement of these lymphocytes in plaque disruption.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.

              HDL cholesterol (HDL-C) plasma levels are inversely related to cardiovascular disease risk. Previous studies have shown in animals and humans that HDL promotes regression of atherosclerosis. We hypothesized that this was related to an ability to promote the loss of monocyte-derived cells (CD68(+), primarily macrophages and macrophage foam cells) from plaques. To test this hypothesis, we used an established model of atherosclerosis regression in which plaque-bearing aortic arches from apolipoprotein E-deficient (apoE(-/-)) mice (low HDL-C, high non-HDL-C) were transplanted into recipient mice with differing levels of HDL-C and non-HDL-C: C57BL6 mice (normal HDL-C, low non-HDL-C), apoAI(-/-) mice (low HDL-C, low non-HDL-C), or apoE(-/-) mice transgenic for human apoAI (hAI/apoE(-/-); normal HDL-C, high non-HDL-C). Remarkably, despite persistent elevated non-HDL-C in hAI/apoE(-/-) recipients, plaque CD68(+) cell content decreased by >50% by 1 wk after transplantation, whereas there was little change in apoAI(-/-) recipient mice despite hypolipidemia. The decreased content of plaque CD68(+) cells after HDL-C normalization was associated with their emigration and induction of their chemokine receptor CCR7. Furthermore, in CD68(+) cells laser-captured from the plaques, normalization of HDL-C led to decreased expression of inflammatory factors and enrichment of markers of the M2 (tissue repair) macrophage state. Again, none of these beneficial changes were observed in the apoAI(-/-) recipients, suggesting a major requirement for reverse cholesterol transport for the beneficial effects of HDL. Overall, these results establish HDL as a regulator in vivo of the migratory and inflammatory properties of monocyte-derived cells in mouse atherosclerotic plaques, and highlight the phenotypic plasticity of these cells.
                Bookmark

                Author and article information

                Journal
                J Am Heart Assoc
                J Am Heart Assoc
                ahaoa
                JAH3
                Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
                Blackwell Publishing Ltd
                2047-9980
                February 2012
                20 February 2012
                : 1
                : 1
                : 27-41
                Affiliations
                Clinical Cardiovascular Biology Centre, San Raffaele Scientific Institute and the Università Vita-Salute San Raffaele , Milan, Italy (E.A., D.C., M.B.)
                Flow cytometry Resource Analytical Cytology Technical Applications Laboratory, San Raffaele Scientific Institute and the Università Vita-Salute San Raffaele , Milan, Italy (V.V., A.G.P.)
                Clinical Immunology Unit, San Raffaele Scientific Institute and the Università Vita-Salute San Raffaele , Milan, Italy (A.A.M.)
                Heart Transplantation Division, Ospedale Niguarda Ca' Granda , Milan, Italy (E.A.)
                Centro Cardiologico Monzino, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Milan, Italy, Department of Cardiovascular Sciences, University of Milan Milan, Italy (M.D.M.)
                Center for the Study of Atherosclerosis, Italian Society for the Study of Atherosclerosis Lombardia Chapter, Bassini Hospital Cinisello Balsamo Milan, Italy (L.G., F.P., K.G., S.T., G.D.N.)
                Department of Pharmacological Sciences, Università degli Studi di Milano , Milan, Italy (A.L.C., G.D.N.)
                Multimedica IRCCS, S.S. Giovanni , Milan (L.G., A.L.C.)
                Heart Care Foundation , Florence, Italy (E.A., A.M.)
                Author notes
                Correspondence to: Enrico Ammirati, MD, San Raffaele Scientific Institute and the Università Vita-Salute San Raffaele, via Olgettina 58, 20132 Milan, Italy. E-mail ammirati.enrico@ 123456hsr.it Or Giuseppe Danilo Norata, PhD, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy. E-mail Danilo.Norata@ 123456unimi.it
                Article
                jah34
                10.1161/JAHA.111.000125
                3487313
                23130116
                59638d86-cb71-40f7-9f14-65db4f84e313
                © 2012 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley-Blackwell.

                This is an Open Access article under the terms of the Creative Commons Attribution Noncommercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 07 December 2011
                : 21 December 2011
                Categories
                Original Research
                Molecular Cardiology

                Cardiovascular Medicine
                coronary artery disease,effector memory t cells,atherosclerosis,c-c chemokine receptor type 7,chemokines

                Comments

                Comment on this article